Clare Market Investments’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,667
Closed -$429K 188
2021
Q4
$429K Sell
4,667
-3,725
-44% -$445K 0.12% 88
2021
Q3
$1.06M Buy
8,392
+450
+6% +$65.5K 0.32% 45
2021
Q2
$1.32M Sell
7,942
-943
-11% -$153K 0.42% 32
2021
Q1
$1.61M Buy
8,885
+4,519
+104% +$1.05M 0.61% 30
2020
Q4
$873K Buy
4,366
+1,096
+34% +$223K 0.37% 40
2020
Q3
$717K Buy
+3,270
New +$692K 0.35% 44
2020
Q2
Sell
-3,525
Closed -$546K 97
2020
Q1
$546K Buy
+3,525
New +$410K 0.46% 37

Other funds holding TDOC

Clare Market Investments's TDOC Position: Q1 2022 in Review

Clare Market Investments sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 4,667 shares — an estimated $429K sold.

Clare Market Investments first reported a position in TDOC in Q1 2020 and held it in 7 quarters. The position peaked at $1.61M in Q1 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Clare Market Investments reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Clare Market Investments sold 4,667 Teladoc Health shares in Q1 2022, an estimated $429K.
  • Clare Market Investments first reported a position in Teladoc Health in Q1 2020 and held it in 7 quarters.
  • Clare Market Investments's Teladoc Health position peaked at $1.61M in Q1 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Clare Market Investments's 13F filing for Q1 2022, filed 20 Feb 2025.